Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.44
(
-1.25%
)
Bitcoin
80,995.01
(
0.63%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Krakonos

Send PM Follow Ignore
Followers 31
Posts 1831
Boards Moderated 0
Alias Born 01/05/2011

Krakonos

Re: md1225 post# 233648

Saturday, 09/05/2015 7:08:15 PM

Saturday, September 05, 2015 7:08:15 PM

Post# of 347009
md1225 please help me out.

In all reality I envision a buyout to the tune of 20 Billion this time next year if trial halted by March 2016. Then Bristol Myers can make Bavituximab SOC for all cancers added to an ever changing immunotherapy, chemotherapy, radiation and surgery assault.



Slip of the tongue or just flapping as usual?

You are implying that it will be Bristol Myers, who will be buying out PPHM.
Care to clear this conviction of yours?

BAVITUXIMAB - billions and billions will be served.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote